Introduction
Staphylococcal resistance to macrolide-lincosamidestreptogramin B (MLS) antibiotics is commonly mediated by the genes ermA, ermB or ermC [l, 21 . While the transposon-encoded genes ermA and ermB have rarely been detected in staphylococci, the plasmid-encoded gene ermC is the predominant MLS resistance gene in staphylococcal isolates from both man and animals [3] . The ermC gene has been found on small plasmids of 2.3-4.0 kb [l, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . Two different types of plasmids have been described so far, between which homology has been limited to the ermC region. The 3.7-kb plasmid pE194 from Staphylococcus aureus [7] represents one type of ermC plasmid, the 2.35-kb plasmid pNE131 from S. epidermidis [8] the other type. Expression of the ermC gene has been found to be either inducible by 14-and 1 5-membered macrolides or constitutive [ 17, 1 81 . The genetic basis for the differences of both types of ermC gene expression is in the ermC regulatory region, which is located immediately upstream of the ermC structural gene. The regulatory region of inducible ermC genes is referred to as the translational attenuator and comprises two pairs of inverted repeated sequences as well as a small open reading frame for a regulatory peptide [7, 8, [19] [20] [21] . Changes from the inducible to the constitutive type of ermC gene expression involve structural alterations in the translational attenuator. So far, two types of structural changes have been reported: (i) sequence deletions of varying extent [4, 8, 10 , 221 and (ii) sequence duplications at different locations in the translational attenuator [9, 12, 231. This study identified a novel ermC-encoding MLSresistance plasmid, designated pSES2 1, from 5'. hyicus and describes its ermC structural gene and the regulatory region.
Materials and methods

Bacterial strains and determination of macrolidelincosamide resistance
Cloning and sequence analysis Plasmid pSES21 was linearised by digestion with the restriction endonucleases EcoRI, Xba I, Bam HI, Hpa 11, Hind111 and Hae 111. The entire linearised plasmids were cloned into pBluescript I1 SK+ (Stratagene, Heidelberg, Germany) and the recombinant plasmids were transformed into Escherichia coZi JM107 [30, 311. To localise the position of the pSES2 1 -encoded erm gene by its functional inactivation, the transformants were grown overnight at 37°C in nutrient agar supplemented with erythromycin 150 mg/L.
The strain of S. hyicus was isolated from the skin swab of a tylosin-fed pig and identified by the ID32 STAPH system (bioMkrieux, La Balme les Grottes, France). Resistance to macrolide-lincosamide antibiotics was determined by the agar diffusion test [24] with disks (Becton-Dickinson, Heidelberg, Germany) containing erythromycin 15 pg, lincomycin 10 pg, or clindamycin 10 pg or tablets (Hiss Diagnostics, Freiburg, Germany) containing azithromycin 30 pg, spiramycin 200 pg or tylosin 150 pg. S. aureus RN4220 served as the recipient for plasmid pSES2 1 in protoplast transformation experiments [25] . During the further course of the study, the original S. hyicus strain, as well as S. aureus RN4220:pSES2 1 were grown on sheep blood agar (Oxoid) supplemented with erythromycin 30 mg/L. S. aureus RN4220 carrying plasmid pSES5, which encodes the inducible ermC gene [ll] , served as control for the determination of the type of ermC gene expression.
Plasmid analysis and Southern blot hybridisation
The single plasmid found in the original S. hyicus isolate was transformed into S. aureus RN4220 by polyethylene glycol-mediated protoplast transformation [25, 261 ; S. aureus RN4220:pSES21 transformants were subsequently selected on DM3 regeneration plates [26] supplemented with erythromycin 30 mg/L. The plasmid, designated pSES2 1, was isolated by affinity chromatography [27] (Qiagen Midi System, Hilden, Germany) and subjected to restriction endonuclease digests (Boehringer Mannheim, Germany). Uncleaved plasmid pSES21 as well as its restriction fragments were separated in agarose 1-1.5% w/v gels with 1 X TAE buffer as running buffer. The sizes of the fragments were calculated from logarithmic plots by comparison with the 1-kb ladder (Gibco-BRL, Eggenstein, Germany). To determine the class of erm gene, hybridisation experiments were conducted with the following gene probes: the 472-bp Hue III/ HincII internal fragment of the ermC gene of plasmid pE194 served as ermC gene probe [7] ; the 1.46-kb CZaI fragment of plasmid pSES20 as ermB gene probe [28] ; and the 1.21-kb ClaI-EcoRV fragment of transposon Tn554 as ermA probe [29] . Plasmid DNA was transferred from agarose gels to nitrocellulose membranes by the capillary blot procedure [27] . The probes were labelled with the non-radioactive enhanced chemiluminescence system (ECL, Amersham-Buchler, Braunschweig, Germany). High stringency hybridisation conditions were as previously described [27] and the signal was detected with the detection reagents supplied with the ECL kit.
Plasmid pBluescript I1 SK+, which carried the HindIII-linearised pSES2 1, was chosen for sequence analysis. Initial sequence analyses were performed with the commercially available M 13 universal and T3 primers (Stratagene). For additional sequence analyses, four 14-18-mer primers derived from the sequence data obtained were used. Sequence analyses were performed on both strands by the dideoxy chain termination method [32] with the Sequenase 2.0 kit and [a32S]dATP or by automated nonradioactive sequencing with the AutoReadTM sequencing kit (Pharmacia) and the ALF DNA analysis system (Pharmacia). The calculation of mRNA stabilities followed the recommendations of Tinoco et aZ. [33] . Dice coefficients of similarity [34] were calculated to compare the deduced amino-acid sequences of the ErmC methylases encoded by the plasmids pE194 [7] , pIM13 [22] , pT48 [5] , pNE131 [8] , pSES4a [Ill, pSES5 [ll] , pSES6 [9, 111 and pSES2 1.
Nucleotide sequence accession number
The nucleotide sequence of the pSES2 1 -encoded ermC gene and its regulatory region has been submitted to the EMBL database and assigned accession number Y09003.
Results
Analysis of the pSES21-encoded ermC gene
The 4.0-kb plasmid pSES21 from S. hyicus was shown by protoplast transformation to mediate macrolidelincosamide resistance. Hybridisation with specific gene probes for staphylococcal erm genes demonstrated that the pSES21-encoded erm gene belonged to the hybridisation class C. Although pSES2 1 resembled the MLS resistance plasmids pE194 and pSES6 in size, restriction mapping did not reveal homology of pSES21 to either of the two types of ermC plasmids, so far described in staphylococci (Fig. 1) . Particularly, the characteristic arrangement of Sac I, Hae 111, BcZI and CZaI sites within the ermC gene region was missing in pSES2 1. 
Analysis of the ermC translational attenuator and transcriptional terminator
Plasmid pSES2 1 conferred combined resistance to 14-, 15-and 16-membered macrolides and also to lincosamides without previous induction by erythromycin. This resistance pattern confirmed that the pSES21-encoded ermC gene was expressed constitutively. A comparison of the pSES2 1 -encoded ermC translational attenuator with the corresponding region of pE 194 revealed the presence of 14 base-pair insertions and another 2 1 base-pair substitutions within the 188-bp region preceding the ermC structural gene (Fig. 2) . Conversion of C to T at position 17 deleted the SacI cleavage site while the insertion of an additional G at position 19 and the substitution of T by C at position 20 generated a new CfoI cleavage site. Five base-pair insertions were located in the reading frame of the small regulatory peptide with one of them deleting the start codon (ATG-ATTG). No other start codon was found in this region that could functionally replace this deleted start codon. The inverted repeated segments were also affected by base-pair substitutions (Fig. 2) The base-pair substitutions also generated a new pair of inverted repeated segments, designated 5 5 , which encompassed parts of segments 2 and 3. The free energy of pairing of segments 5:6 was calculated to be AG = -1 1.0 kcal (c. 46.1 kJ)/mol. The calculation of the free energies of the different mRNA secondary structures confirmed that there will be a greater tendency for segments 5:6 to form the energetically most stable secondary structure, than for segments 1:2 or 2:3 to form a stem-loop structure. If segments 5:6 pair, there is no partner left for segment 4 to form a secondary stucture. Moreover, the unpaired state of segment 4 will render the ribosome-binding site for the ermC structural gene which is located within segment 4 accessible to ribosomes and so allow constitutive ErmC synthesis to occur.
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The transcriptional terminator, composed of another two inverted repeated sequences 7 and 8, starts in the translational stop codon of the ermC structural gene. It also showed several base-pair exchanges which destabilised the secondary structure obtained from pairing of segments 7:8 from AG = -28.4 kcal (c. 118.9 kJ)/mol in pE194 to AG = -21.4 kcal (c. 89.6 kJ)/mol in pSES21. Moreover, conversion of A to G at positions 932 and 936 (Fig. 3) destroyed the recognition sequence for the restriction enzyme CZa I.
Discussion
Antibiotics of the MLS group can be subdivided into two groups: (i) the inducers of ermC gene expression which include 14-and 15-membered macrolides and (ii) the non-inducers which comprise 16-membered macrolides, lincosamides and streptogramin B antibiotics [ 17, 181 . Staphylococci that carry inducible ermC genes are resistant only to inducers. This led to the assumption that inducibly ermC resistant staphylococci can effectively be treated with non-inducing members of the MLS group of antibiotics. However, such inducibly ermC resistant strains were found to be able to mutate to constitutive resistance in the presence of non-inducers [35] . First observations of this change of the type of gene expression [36] were made some time before the first ermC gene was sequenced and the translation attenuation model [19, 371 for inducible ermC gene expression was proposed. Several years later, in-vitro studies of constitutive mutants selected from inducibly ermC resistant strains on media containing tylosin, clindamycin, spiramycin or pristinamycin revealed structural alterations in the ermC translational attenuator [20, 23, 35, 381. Two types of alterations were observed: sequence deletions and sequence duplications. The 59-bp deletion detected by Horinouchi and Weisblum [20] comprised the entire reading frame for the 19 aminoacid peptide including the inverted repeated segment 1. Constitutive mutants selected from clinical specimens also exhibited sequence deletions of varying extent within the translational attenuator [4, 8, 101 . A deletion of 107 bp which removed the reading frame for the small peptide and also the inverted segments 1, 2 and 3, was found to occur most frequently [lo] . Besides these sequence deletions, a direct tandem duplication of 109 bp of the translational attenuator was observed in a constitutive mutant selected in vitro [23] . Other tandem duplications were seen in vivo in epidemiologically unrelated staphylococcal strains. Thus, duplication of a 28-bp fragment which contained parts of the inverted repeats 1 and 2 was detected in plasmid pRJ5 from S. aureus [12] while Lodder et al. [9] described the duplication of a 23-bp fragment which included the inverted repeat 4 and the first 5 bp of the ermC structural gene to be present in plasmid pSES6 from S. equorum.
First indications for the in-vitro selection of uninducible/constitutive mutants by point mutation of important positions within the translational attenuator were obtained from analysis of the vc-1 mutant of plasmid pE194 [23] . The conversion from A to C within the translational start codon of the reading frame for the small peptide deleted this start codon and was considered to be responsible for constitutive ermC gene expression [23] . The assumption that translation of the small peptide is required for ermC induction was confirmed by Dubnau [39] who obtained an uninducible mutant by replacing the second codon of the 19 amino-acid peptide by a stop codon. While these mutations were selected randomly under laboratory conditions [ 231 or introduced artificially [39] , data have not been available to confirm the occurrence of similar mutations in vivo. The data obtained from the naturally occurring plasmid pSES21, however, might fill this gap. Multiple basepair exchanges and insertions were detected in the pSES2 1 -encoded translational attenuator, several of which affected structures of importance for the regulation of the ermC gene. Deletion of the translational start codon for the small regulatory peptide in combination with frame-shift mutations in the reading frame destroyed this regulatory element. As the first nine codons of this small 19 amino-acid peptide are crucial for stalling a ribosome during induction [35, 40, 411 , deletion of the reading frame for this small peptide might explain the uninducibility of the pSES21-encoded ermC gene. However, lack of inducibility does not consequently result in constitutiveness. As long as segments 1:2 and 3:4 form stable mRNA secondary structures and no ribosome is stalled in the region of segment 1, the ermC-associated ribosomal binding site and the start codon for the ermC methylase gene will be buried within the stemloop structure 3:4 and therefore remain unaccessible to ribosomes. In pSES2 1, the base-pair substitutions within the inverted repeated segments mainly affected segments 1 and 2 and distinctly decreased the stability of mRNA secondary structures formed by pairing of 1:2 as well as 2:3, Pairing of the newly generated inverted repeats 5:6, which include part of segment 2 and the entire segment 3, might explain the constitutive type of ermC gene expression. Pairing of segments 5:6 will lead to the energetically most stable stem-loop structure and well leave segment 4 unpaired. Thus, the ermC-associated ribosome-binding site and the start codon for the ermC methylase gene will become accessible to ribosomes.
Previous studies have shown that an inducibly ermC resistant strain is able to mutate to constitutive ermC gene expression with a high probability [35] . The corresponding mutations were all located in the ermC translational attenuator and similar if not identical mutations were found under laboratory conditions as well as in vivo. The rapid development of constitutive resistance by sequence deletions or sequence duplications might be explained by an apparent single mutational step [35] . The observation that the corresponding ErmC methylases encoded by plasmids such as pSES6, pSES4a, pNE131 or pIM13 were either identical to that of pE194 or differed from it by 4, 5 or 6 amino acids confirmed that mutation to constitutive resistance was not accompanied by extensive alterations in the ermC structural gene, but remained mainly limited to the translational attenuator.
Comparison of the deduced amino-acid sequences of the sequenced ermC genes of staphylococci and bacilli showed that the ErmC methylases are very closely related (Fig. 3a, b) , however, with the pSES21-encoded ErmC methylase differing the most from all other adenine methylases of this hybridisation class. It is not known how many mutational steps during which time have been necessary to change the pSES21-encoded ermC translational attenuator from an inducible type to its present constitutive type and to account for the 16-amino-acid exchanges within the ermC methylase gene.
From the clinical point of view, mutation from inducible to constitutive resistance is accompanied by a widening of the spectrum of antibiotics to which resistance is expressed, which means from limited resistance to 14-and 15-membered macrolides in inducibly resistant strains to overall resistance to 14-, 1 5 , and 16-membered macrolides, lincosamides and streptogramin B antibiotics in constitutively resistant strains. The use of non-inducing MLS antibiotics as growth promoters in livestock might favour the occurrence of mutations to constitutive resistance. A recent study [ 101 revealed that randomly selected erm C-carrying strains from various domestic animals showed a strong correlation between the type of ermC gene expression and the previous contact of the animal to non-inducing MLS antibiotics. While none of the animals which carried inducibly ermC resistant staphylococcal strains had any previous contact with 16-membered macrolides, lincosamides or streptogramins, most of the constitutively ermC resistant strains were obtained from animals that had received 16-membered macrolides as growth promoters or lincosamides for therapeutic purposes. Knowledge of the mutational events that cause a change in the type of ermC gene expression and of the consequences for the effectiveness of MLS antibiotics to control macroli de -re si s t ant staphylococci demand a careful and judicious use of non-inducing MLS antibiotics. This may include a restriction of the use of 16-membered macrolides as growth promoters in livestock.
